Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $26.7M | $17.5M | $88.5M | $2.05M | $2.60M | — | $10.0M | $30.9M |
| Revenue growth | — | — | — | -34.7% | 407.1% | -97.7% | 26.4% | — | — | 209.1% |
| Operating income | -$37.0M | -$67.8M | -$94.8M | -$132M | -$49.4M | -$61.4M | -$72.9M | -$92.1M | -$115M | -$170M |
| Operating margin | — | — | -354.8% | -758.1% | -55.8% | -2991.2% | -2809.6% | — | -1149.6% | -550.3% |
| Net income | -$36.4M | -$67.8M | -$72.4M | -$149M | -$67.7M | -$71.2M | -$73.8M | -$87.4M | -$131M | -$209M |
| Net margin | — | — | -271.1% | -854.8% | -76.5% | -3468.1% | -2843.3% | — | -1306.4% | -677.6% |
| EPS (diluted) | -$0.99 | -$1.76 | -$1.37 | -$2.00 | -$0.44 | -$4.90 | -$4.57 | -$3.96 | -$3.66 | -$3.02 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$29.5M | -$57.3M | -$74.5M | -$139M | -$33.5M | -$53.5M | -$63.7M | -$86.5M | -$105M | -$138M |
| Capital expenditures | $39.0K | — | $1.51M | $7.00K | $33.0K | $196K | — | — | $28.0K | — |
| Free cash flow | -$29.5M | — | -$76.0M | -$139M | -$33.5M | -$53.7M | — | — | -$105M | — |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $32.3M | $82.2M | $130M | $43.5M | $67.8M | $21.3M | $74.9M | $77.9M | $88.8M | $205M |
| Total assets | $83.6M | $89.8M | $277M | $145M | $154M | $109M | $95.0M | $150M | $102M | $246M |
| Total liabilities | $11.3M | $32.1M | $153M | $138M | $39.1M | $21.1M | $47.7M | $71.2M | $130M | $189M |
| Long-term debt | — | $15.0B | — | — | — | — | $24.5M | $40.1M | $40.7M | — |
| Shareholders' equity | $72.3M | $57.7M | $124M | $7.17M | $115M | $87.6M | $47.4M | $57.4M | -$28.9M | $57.2M |
| Retained earnings | -$235M | -$303M | -$376M | -$525M | -$593M | -$664M | -$738M | -$825M | -$956M | -$1.16B |
| Shares (wtd avg diluted) | 37.0M | 38.4M | 69.3M | 74.6M | 153K | 14.5M | 16.1M | 22.1M | 35.7M | 69.3M |
Every figure is extracted from Verastem, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.